These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 11384204

  • 1. Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A.
    Lavagno L, Bordin G, Colangelo D, Viano I, Brunelleschi S.
    Neuropeptides; 2001 Apr; 35(2):92-9. PubMed ID: 11384204
    [Abstract] [Full Text] [Related]

  • 2. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
    Brunelleschi S, Nicali R, Lavagno L, Viano I, Pozzi E, Gagliardi L, Ghio P, Albera C.
    Neuropeptides; 2000 Feb; 34(1):45-50. PubMed ID: 10688968
    [Abstract] [Full Text] [Related]

  • 3. Tachykinin receptors on human monocytes: their involvement in rheumatoid arthritis.
    Brunelleschi S, Bordin G, Colangelo D, Viano I.
    Neuropeptides; 1998 Jun; 32(3):215-23. PubMed ID: 10189055
    [Abstract] [Full Text] [Related]

  • 4. Neurokinin receptor modulation of respiratory activity in the rabbit.
    Bongianni F, Mutolo D, Cinelli E, Pantaleo T.
    Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [Abstract] [Full Text] [Related]

  • 6. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
    Lecci A, Capriati A, Altamura M, Maggi CA.
    Auton Neurosci; 2006 Jun 30; 126-127():232-49. PubMed ID: 16616700
    [Abstract] [Full Text] [Related]

  • 7. Effect of neurokinins on canine prostate cell physiology.
    Walden PD, Marinese D, Srinivasan D, Tzoumaka E, Syyong HT, Ford AP, Bhattacharya A.
    Prostate; 2005 Jun 01; 63(4):358-68. PubMed ID: 15611996
    [Abstract] [Full Text] [Related]

  • 8. Tachykinin receptors are present on human monocytes and play a role in rheumatoid arthritis.
    Brunelleschi S, Colangelo D, Bordin G, Viano I.
    J Chemother; 1998 Apr 01; 10(2):150-2. PubMed ID: 9603643
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of neurokinin-1 receptor messenger RNA expression in synovial fibroblasts of patients with rheumatoid arthritis.
    Akasaka Y, Abe K, Sato T, Inoue H.
    Neuropeptides; 2005 Oct 01; 39(5):467-74. PubMed ID: 16154193
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K.
    Arthritis Rheum; 2004 Feb 01; 50(2):432-43. PubMed ID: 14872485
    [Abstract] [Full Text] [Related]

  • 12. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
    Meusch U, Rossol M, Baerwald C, Hauschildt S, Wagner U.
    Arthritis Rheum; 2009 Sep 01; 60(9):2612-21. PubMed ID: 19714631
    [Abstract] [Full Text] [Related]

  • 13. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T, Shirahase H, Kanda M, Kunishiro K, Kurahashi K.
    Vascul Pharmacol; 2009 Sep 01; 51(2-3):147-53. PubMed ID: 19539781
    [Abstract] [Full Text] [Related]

  • 14. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):140-8. PubMed ID: 16979621
    [Abstract] [Full Text] [Related]

  • 15. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M.
    Neuro Endocrinol Lett; 2005 Aug 07; 26(4):367-72. PubMed ID: 16136007
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist.
    Gitter BD, Waters DC, Threlkeld PG, Lovelace AM, Matsumoto K, Bruns RF.
    Eur J Pharmacol; 1995 May 26; 289(3):439-46. PubMed ID: 7556412
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
    Ganjiwale A, Cowsik SM.
    Mini Rev Med Chem; 2013 Dec 26; 13(14):2036-46. PubMed ID: 23937231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.